ASH Letter to FDA and Intl Conference on Harmonization re Draft Guideline for Good Clinical Practice
Citations
91国产精品. (2023).
ASH Letter to FDA and Intl Conference on Harmonization re Draft Guideline for Good Clinical Practice.
Retrieved from /advocacy/policy-news-statements-testimony-and-correspondence/testimony-and-correspondence/ash-letter-to-fda-and-intl-conference-on-harmonization-re-draft-guideline-for-good-clinical-practice.
91国产精品.
"ASH Letter to FDA and Intl Conference on Harmonization re Draft Guideline for Good Clinical Practice." Hematology.org.
/advocacy/policy-news-statements-testimony-and-correspondence/testimony-and-correspondence/ash-letter-to-fda-and-intl-conference-on-harmonization-re-draft-guideline-for-good-clinical-practice
(label-accessed September 19, 2024).
"91国产精品."
ASH Letter to FDA and Intl Conference on Harmonization re Draft Guideline for Good Clinical Practice, 19 Sep. 2024 ,
/advocacy/policy-news-statements-testimony-and-correspondence/testimony-and-correspondence/ash-letter-to-fda-and-intl-conference-on-harmonization-re-draft-guideline-for-good-clinical-practice.